asa guidelines glp-1 How should we approach patients on agonists? Check out this excellent editorial from Dr. Girish Joshi, "Clarifying the and Decoding the Enigma: Strategies for Anesthetic Management of Patients on Glucagon-Like Holding GLP-1 Agonists Prior to

Once-Monthly Maridebart Cafraglutide for the Treatment of Obesity A Phase 2 Trial

With fully online telehealth weight-loss visits, residents across Newark and New Jersey can now access GLP-1 weight-loss injections, including Mounjaro, Zepbound, Semaglutide, and Tirzepatide, without having to visit a clinic in person

Availability Disclaimer: Program availability varies by state and is not available in all 50 states

Lassen, M

doi:10.1016/j.mehy.2004.03.037 9

Prior Authorization Requirements When Anthem does cover Wegovy or Zepbound, it typically requires prior authorization: Clinical Requirements BMI of 30 or higher, OR BMI of 27 or higher with at least one weight-related condition Documentation Requirements Medical records supporting the diagnosis Evidence of previous weight loss attempts Sometimes: trial of other weight loss medications first (step therapy) Initial approval period: Typically 6 to 12 months